A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The average weight loss among those taking the new drug was 15.7% after 68 weeks, compared to 3.1% for those taking a placebo. Shares sank to their lowest point in over a year after the release of ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month ... the FDA said the shortage was over and told compounders to stop making copies of weight-loss drugs by May.

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

The move comes just over a week after rival Eli Lilly cut the price for vials of its weight-loss ... copies of Wegovy while the medicines were in shortage are also running out of time to produce ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.